Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement

Background: Molecular biomarkers have the potential to improve the current state of early lung cancer detection. The goal of this project was to develop a policy statement that provides guidance about the level of evidence required to determine that a molecular biomarker, used to support early lung...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Respir Crit Care Med
Main Authors: Mazzone, Peter J., Sears, Catherine Rufatto, Arenberg, Doug A., Gaga, Mina, Gould, Michael K., Massion, Pierre P., Nair, Vish S., Powell, Charles A., Silvestri, Gerard A., Vachani, Anil, Wiener, Renda Soylemez
Format: Artigo
Jezik:Inglês
Izdano: American Thoracic Society 2017
Teme:
American Thoracic Society Documents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803661/
https://ncbi.nlm.nih.gov/pubmed/28960111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201708-1678ST
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki